Stanford University
Showing 1,171-1,180 of 1,602 Results
-
Sushma Reddy
Associate Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsMy laboratory's expertise in cardiovascular phenotyping has led to the development of mouse models of congenital heart disease that recapitulate abnormal loading conditions on the heart. We have used these models to advance our understanding of the mechanisms of right heart failure in children and adults with congenital heart disease with the long term goal of identifying noninvasive diagnostic tools to better assess right ventricular health and to develop right ventricle specific therapeutics.
-
Shobha Regmi
Research Scientist, Pediatrics - Gastroenterology
BioDr. Regmi earned her PhD in Pharmacy from Yeungnam University, South Korea. Before joining us, she was a postdoctoral fellow in the Department of Radiology under the mentorship of Dr. Avnesh S. Thakor. With over a decade of experience researching novel therapies for inflammatory diseases and expertise in cell therapy, Dr. Regmi brings valuable skills in in vivo and in vitro experimental biology, immunology, complex multicolor flow cytometry, and scientific writing. Her expertise will be instrumental in advancing the Rosen Lab’s research on the molecular mechanisms underlying pediatric IBD and treatment response.
Dr. Regmi’s work will focus on investigating the role of stromal-immune crosstalk that drives ulcerative colitis. -
David Rehkopf
Director, Stanford Center on Longevity, Professor of Epidemiology and Population Health, of Sociology, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, and of Health Policy
BioI am a social epidemiologist and Professor in the Department of Epidemiology and Population Health, the Department of Sociology, and the Division of Primary Care and Population Health in the Department of Medicine. I joined the Stanford University faculty in 2011.
My research examines the health implications of the myriad decisions made every day by corporations and governments—decisions that profoundly shape the social and economic worlds in which we live and work. Although these changes are often invisible in daily life, seemingly minor actions and decisions can serve as structural nudges that produce better or worse health at the population level. My work documents the health consequences of corporate and governmental decisions, providing evidence that can help the public and policymakers develop new strategies to promote health and well-being. Across this work, I focus particularly on the implications of these exposures for health inequalities.
Because policy and programmatic changes can take decades to influence health, my research also includes more basic work to identify biological signals that may serve as early warning signs of systemic disease, particularly accelerated aging. I examine how social and economic policy changes affect a range of early markers of disease and aging, with a recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop more sensitive approaches for understanding the health effects of social and economic policy changes. -
Jenna Reisler
Fellow in Peds/Clinical Informatics
BioJenna Reisler, MD is an Internal Medicine-trained Clinical Informatics Fellow passionate about designing clinical decision support tools that reduce clinician burden and improve patient outcomes. Her work spans CDS for falls prevention, human-centered EHR workflow design, and quality improvement in ambulatory care and inpatient settings. Recent projects include a co-investigator role on an EPIC-based falls prevention CDS tool published in Applied Clinical Informatics, and co-PI of an ACGME Back to Bedside–funded home visit program integrating social determinants of health into residency training.
